Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.
Access endometrial cancer specialists in Tampa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometrial cancer treatment provided free
This is a 2 stage multi-center study designed to evaluate the efficacy of the combination of alpelisib and fulvestrant in patients with PIK3CA-mutated ER-positive endometrioid endometrial cancers by estimating the objective response rate (ORR). Treatment will continue until either unacceptable toxicity, progression of disease, or investigator/patient request for withdrawal.
Sponsor: GOG Foundation
Check if you qualify for this endometrial cancer clinical trial in Tampa, FL
If you're searching for endometrial cancer treatment options in Tampa, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tampa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.